IL29369A - Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl)pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines - Google Patents

Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl)pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines

Info

Publication number
IL29369A
IL29369A IL29369A IL2936968A IL29369A IL 29369 A IL29369 A IL 29369A IL 29369 A IL29369 A IL 29369A IL 2936968 A IL2936968 A IL 2936968A IL 29369 A IL29369 A IL 29369A
Authority
IL
Israel
Prior art keywords
methyl
thienyl
formate
trimethylene
process according
Prior art date
Application number
IL29369A
Other languages
English (en)
Original Assignee
Pfizer & Co C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer & Co C filed Critical Pfizer & Co C
Publication of IL29369A publication Critical patent/IL29369A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL29369A 1967-02-14 1968-01-24 Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl)pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines IL29369A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61589767A 1967-02-14 1967-02-14
US64339167A 1967-06-05 1967-06-05
US68190767A 1967-11-09 1967-11-09

Publications (1)

Publication Number Publication Date
IL29369A true IL29369A (en) 1971-05-26

Family

ID=27417162

Family Applications (1)

Application Number Title Priority Date Filing Date
IL29369A IL29369A (en) 1967-02-14 1968-01-24 Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl)pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines

Country Status (11)

Country Link
US (1) US3502661A (US06580902-20030617-M00005.png)
BE (1) BE710492A (US06580902-20030617-M00005.png)
CH (1) CH498124A (US06580902-20030617-M00005.png)
DE (1) DE1695602C3 (US06580902-20030617-M00005.png)
ES (1) ES350283A1 (US06580902-20030617-M00005.png)
FR (1) FR1588187A (US06580902-20030617-M00005.png)
GB (1) GB1195454A (US06580902-20030617-M00005.png)
IE (1) IE32035B1 (US06580902-20030617-M00005.png)
IL (1) IL29369A (US06580902-20030617-M00005.png)
IT (1) IT1047904B (US06580902-20030617-M00005.png)
NL (1) NL154509B (US06580902-20030617-M00005.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006137A (en) * 1975-08-21 1977-02-01 E. R. Squibb & Sons, Inc. 2-Ethenyl imidazolium derivatives
US4087536A (en) * 1976-05-04 1978-05-02 The Dow Chemical Company Method for the use of thienylvinylimidazoles as anthelmintics
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
FR2482859A1 (fr) * 1980-05-22 1981-11-27 Fabre Sa Pierre Fluorhydrates d'heterocycles azotes insatures utilisables en therapeutique dentaire
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7396819B2 (en) 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
US8211905B1 (en) 2007-05-22 2012-07-03 Pisgah Laboratories, Inc. Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
US20080293695A1 (en) 2007-05-22 2008-11-27 David William Bristol Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
US8039461B1 (en) 2006-11-10 2011-10-18 Pisgah Laboratories, Inc. Physical states of a pharmaceutical drug substance
US7858663B1 (en) 2007-10-31 2010-12-28 Pisgah Laboratories, Inc. Physical and chemical properties of thyroid hormone organic acid addition salts
US7718649B1 (en) 2006-11-10 2010-05-18 Pisgah Labs, Inc. Physical states of a pharmaceutical drug substance
US10183001B1 (en) 2007-05-22 2019-01-22 Pisgah Laboratories, Inc. Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
US9421266B2 (en) 2007-05-22 2016-08-23 Pisgah Laboratories, Inc. Safety of pseudoephedrine drug products
US8329720B1 (en) 2007-05-22 2012-12-11 Pisgah Laboratories, Inc. Opioid salts and formulations exhibiting abuse deterrent and anti-dose dumping properties
US8883863B1 (en) 2008-04-03 2014-11-11 Pisgah Laboratories, Inc. Safety of psuedoephedrine drug products
MX2012001170A (es) 2009-07-30 2012-07-20 Merial Ltd Compuestos de 4-amino-tieno [2,3-d]pirimidina insecticidas y metodos para su uso.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1108207A (en) * 1965-10-07 1968-04-03 Pfizer & Co C Process for preparing 2-Ä2-(substituted) vinylÜcyclic amidines

Also Published As

Publication number Publication date
IT1047904B (it) 1980-10-20
DE1695602C3 (de) 1975-03-13
FR1588187A (US06580902-20030617-M00005.png) 1970-04-10
ES350283A1 (es) 1969-05-16
CH498124A (de) 1970-10-31
DE1695602A1 (de) 1972-04-13
NL154509B (nl) 1977-09-15
IE32035L (en) 1968-08-14
DE1695602B2 (de) 1974-06-20
NL6801459A (US06580902-20030617-M00005.png) 1968-08-15
BE710492A (US06580902-20030617-M00005.png) 1968-08-08
GB1195454A (en) 1970-06-17
IE32035B1 (en) 1973-03-21
US3502661A (en) 1970-03-24

Similar Documents

Publication Publication Date Title
IL29369A (en) Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl)pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines
KR101707246B1 (ko) 고체 형태의 (2ｓ,3ｒ,4ｒ,5ｓ,6ｒ)-2-(4-클로로-3-(4-에톡시벤질)페닐)-6-(메틸티오)테트라히드로-2ｈ-피란-3,4,5-트리올 및 그의 사용 방법
AT376976B (de) Verfahren zur herstellung von neuen 5-substituierten oxazolidin-2,4-dionen und ihren salzen
CA2155148A1 (en) Pyrrolocarbazoles
KR940008848B1 (ko) 신규의 9-디아자구아닌
DE60116106T2 (de) Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe
EP0217688B1 (fr) Nouveaux dérivés peptidiques à structure lactonique ou cycloamidique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CA1053239A (en) Imidazo (2,1-b) thiazoles
DD202555A5 (de) Hypoglykaemische 5-substituierte oxazolidin-2,4-dione
KR102458638B1 (ko) 메데토미딘의 합성에서 유용한 3-아릴부탄알과 같은 화합물의 제조 방법
US3458633A (en) Control of helminthiasis with a series of 2-(w-(2-thienyl)alkyl)-,2-(2-(2-thienyl)vinyl)-,and the corresponding isomeric 3-thienyl derivatives of thiazoline and 5,6-dihydro-4h-1,3-thiazine
US4785012A (en) Oxazole anthelmintic agents of marine origin
US4454320A (en) Process for 5-substituted dialuric acids
SU457221A3 (ru) Способ получени дитиенильных производных
ES2926579T3 (es) Proceso para la preparación de compuestos intermedios útiles en la preparación de inhibidores del virus de la Hepatitis C (VHC)
US20110071302A1 (en) Process for preparing intermediate compound for synthesizing an antiulcerant
Dains et al. The Alkyl Derivatives of the Mono Substituted Thiazolidones. I
US2745845A (en) 1-formyl-2-dialkoxymethyl-succinic acid esters and their cyclization to heterocyclic compounds
US3828053A (en) Lower-alkyl-beta-oxo-4-piperidine-n-benzoylpropionates
US3072636A (en) Process for the manufacture of ethyleneimine derivatives
Campaigne et al. Halogen—Lithium Interconversion with Iodothiophenes
Cheney et al. Some Tetrahydrothiophene β-Keto Ester Derivatives
IL28815A (en) 1,3-dioxolan-4-yl-alkyl guanidines and process for preparing same
KR810000688B1 (ko) 2'-하이드록시-2-(5-이소옥사졸일메틸)-6,7-벤조몰판의 제조방법
KR960014356B1 (ko) 비스 (메틸렌디옥시)비페닐 화합물